Silver Book Fact

A 10 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $4.4 trillion to current and future generations.

Murphy K, Topel R. Measuring the Gains from Medical Research: An economic approach. Chicago, IL: The University of Chicago Press; 2003. https://press.uchicago.edu/ucp/books/book/chicago/M/bo3643529.html

Reference

Title
Measuring the Gains from Medical Research: An economic approach
Publisher
The University of Chicago Press
Publication Date
2003
Authors
Murphy K, Topel R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Drugs like bevacizumab- designed to impede the growth of blood vessels and tumors- can cost more than $100,000 per patient.   
  • Thousands of potential cancer medicines in development
     
  • Based on cost-effectiveness consideration, the preferred screening method for colon cancer is a colonoscopy every 10 years after the age of 50.  
  • Medicines in Devlopment for Cancer, 2008  
  • FDA Cancer Approvals for Aug 2014 to July 2015